We are live on
!
Find out more
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
31 hedge funds and large institutions have $38.7M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
15% more funds holding
Funds holding: 27 → 31 (+4)
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
54% less capital invested
Capital invested by funds: $84.2M → $38.7M (-$45.5M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holders Change
+4
Holders Change %
+14.81%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
7
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$4.32M |
| 2 |
Renaissance Technologies
New York
|
+$207K |
| 3 |
VF
Virtu Financial
New York
|
+$94.1K |
| 4 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$65K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$56.9K |
